2021 annual financial data
Mereo BioPharma Group 2021 Operating margin
Direct answer
Operating margin was -57.42%.
Operating income was -28,255,999.14 GBP and net income was 17,174,130 GBP.
Operating cash flow was -7,070,747.97 GBP.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,213,161 GBP
- Operating income
- -28,255,999.14 GBP
- Net income
- 17,174,130 GBP
- Operating cash flow
- -7,070,747.97 GBP